These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
¨
|
|
Preliminary Proxy Statement
|
|
¨
|
|
Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2))
|
|
x
|
|
Definitive Proxy Statement
|
|
¨
|
|
Definitive Additional Materials
|
|
¨
|
|
Soliciting Material Pursuant to Section 240.14a-12
|
|
x
|
No fee required.
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date Filed:
|
|
1.
|
The election of seven directors to serve until the next annual meeting of stockholders of the Company or until their successors are duly elected and qualified, or until their earlier resignation or removal.
|
|
2.
|
The approval of a non-binding advisory vote on executive compensation.
|
|
3.
|
The ratification of the selection of the independent registered public accounting firm for the year ending
December 31, 2015
.
|
|
4.
|
Any other business which may be properly brought before the meeting or any adjournment thereof.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Shares Owned
(a)
|
|
Right to
Acquire (b) |
|
Total Shares
|
|
Percent of
Class (c) |
|||
|
Named Executive Officers and Directors
|
|
|
|
|
|
|
|
|
|||
|
John W. Chisholm
|
|
505,139
|
|
|
1,120,000
|
|
|
1,625,139
|
|
|
2.97%
|
|
Steven A. Reeves
(d)
|
|
279,411
|
|
|
200,000
|
|
|
479,411
|
|
|
*
|
|
Joshua A. Snively, Sr.
|
|
315,470
|
|
|
—
|
|
|
315,470
|
|
|
*
|
|
H. Richard Walton
|
|
137,513
|
|
|
—
|
|
|
137,513
|
|
|
*
|
|
M. Kevin Fisher
(e)
|
|
178,635
|
|
|
—
|
|
|
178,635
|
|
|
*
|
|
Kenneth T. Hern
|
|
45,292
|
|
|
40,894
|
|
|
86,186
|
|
|
*
|
|
John S. Reiland
|
|
8,066
|
|
|
40,894
|
|
|
48,960
|
|
|
*
|
|
L.V. "Bud" McGuire
|
|
58,628
|
|
|
40,894
|
|
|
99,522
|
|
|
*
|
|
L. Melvin Cooper
|
|
54,781
|
|
|
37,618
|
|
|
92,399
|
|
|
*
|
|
Carla S. Hardy
|
|
433,805
|
|
|
—
|
|
|
433,805
|
|
|
*
|
|
Ted D. Brown
|
|
10,239
|
|
|
—
|
|
|
10,239
|
|
|
*
|
|
All executive officers and directors as a group (11 persons)
|
|
2,026,979
|
|
|
1,480,300
|
|
|
3,507,279
|
|
|
6.42%
|
|
5% Beneficial Owners
|
|
|
|
|
|
|
|
|
|||
|
T. Rowe Price Associates, Inc.
(f)
|
|
5,761,762
|
|
|
—
|
|
|
5,761,762
|
|
|
10.54%
|
|
Gates Capital Management, Inc.
(g)
|
|
6,945,163
|
|
|
—
|
|
|
6,945,163
|
|
|
12.71%
|
|
BlackRock, Inc.
(h)
|
|
4,489,860
|
|
|
—
|
|
|
4,489,860
|
|
|
8.22%
|
|
The Vanguard Group
(i)
|
|
3,308,506
|
|
|
—
|
|
|
3,308,506
|
|
|
6.06%
|
|
(a)
|
Except as otherwise disclosed, the persons named in the table have sole voting and investment power of all shares of Common Stock which are beneficially owned by them. Includes the following number of unvested shares of restricted stock for the persons indicated: Mr. Chisholm -
186,707
; Mr. Reeves -
70,357
; Mr. Snively, Sr. -
59,787
; Mr. Walton -
82,318
; Mr. Hern -
7,714
; Mr. Reiland -
7,714
; Mr. McGuire -
7,714
; Mr.Cooper -
7,714
; Ms. Hardy -
4,380
; and Mr. Brown -
4,380
. None of the named executive officers or directors have pledged shares.
|
|
(b)
|
Shares subject to options granted pursuant to the Company’s incentive plans and exercisable within 60 days of
March 5, 2015
. This assumes that all options beneficially owned by the person are exercised for shares of Common Stock.
|
|
(c)
|
Based on an aggregate of
54,640,115
shares of Common Stock issued and outstanding as of
March 5, 2015
.
|
|
(d)
|
Includes shares previously acquired through the Company’s 401(k) Plan.
|
|
(e)
|
Mr. Fisher retired from his position as an executive officer effective March 18, 2014 and remained an employee through April 30, 2014. Ownership information originated from the Form 4 filed with the Securities and Exchange Commission by Mr. Fisher on September 25, 2014 where 178,635 owned shares were reported.
|
|
(f)
|
The address of T. Rowe Price Associates, Inc. is 100 E. Pratt Street, Baltimore, MD 21202. These securities are owned by various individual and institutional investors which T. Rowe Price Associates, Inc. (Price Associates) serves as an investment adviser with power to direct investment and/or sole power to vote the securities. For the purposes of the reporting requirements of the Securities Exchange Act of 1934, Price Associates is deemed to be a beneficial owner of such securities; however, Price Associates expressly disclaims that it is, in fact, the beneficial owner of such securities. Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by Price Associates on February 13, 2015.
|
|
(g)
|
The address of Gates Capital Management, Inc. (“Gates”) is 1177 Avenue of Americas, 46th Floor, New York, NY 10036. Gates Capital Management, Inc., which is controlled by Jeffrey L. Gates, is the managing member of Gates Capital Management GP, LLC, which is the general partner of Gates Capital Management, LP., which is the investment manager of certain Gates Capital Funds. Jeffrey L. Gates exercises voting and dispositive power over the securities held by each of the funds listed above (collectively, the “Funds”). Gates may be deemed to be the beneficial owner of the securities held by the Funds, although all reported securities are owned by the Funds. Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by Gates on February 17, 2015.
|
|
(h)
|
The address of BlackRock, Inc. is 55 East 52nd Street, New York, NY 10022. Matthew J. Fitzgerald exercises voting and dispositive power over the securities held by BlackRock, Inc. Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by BlackRock, Inc. on January 23, 2015.
|
|
(i)
|
The address of The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355. Ownership information originated from the Schedule 13G/A filed with the Securities and Exchange Commission by The Vanguard Group on February 10, 2015.
|
|
Name and Age
|
|
Positions
|
|
Position
Held Since
|
|
John W. Chisholm (60)
|
|
Interim President
|
|
2009
|
|
|
|
President and Chairman of the Board
|
|
2010
|
|
|
|
Chief Executive Officer
|
|
2012
|
|
|
|
|
|
|
|
Steven A. Reeves (64)
|
|
President Downhole Tool Division
|
|
2007
|
|
|
|
Executive Vice President and Chief Operating Officer
|
|
2008
|
|
|
|
Executive Vice President, Business Development and Special Projects
|
|
2009
|
|
|
|
Executive Vice President, Operations, Business Development and Special Projects
|
|
2010
|
|
|
|
Executive Vice President, Operations
|
|
2011
|
|
|
|
|
|
|
|
Joshua A. Snively, Sr. (50)
|
|
President of Florida Chemical Company, Inc., a wholly-owned subsidiary of the Company
|
|
2013
|
|
|
|
Executive Vice President, Research and Innovation
|
|
2013
|
|
|
|
|
|
|
|
H. Richard Walton (66)
|
|
Chief Financial Officer (Interim)
|
|
2013
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
2013
|
|
|
|
|
|
|
|
M. Kevin Fisher (58) *
|
|
Executive Vice President, Global Business Development
|
|
2011
|
|
•
|
The Company reported revenue for the year ended December 31, 2014 of $449.2 million, an increase of $78.1 million, or 21.0%, compared to $371.1 million for the year ended December 31, 2013, and an increase of $136.4 million, or 43.6%, compared to $312.8 million for the year ended December 31, 2012.
|
|
•
|
The Company reported net income for the year ended December 31, 2014 of $53.6 million, or $0.97 per share (fully diluted), compared to $36.2 million, or $0.67 per share (fully diluted), for the year ended December 31, 2013, and to $49.8 million, or $0.97 per share (fully diluted), for the year ended December 31, 2012. Net income in 2012 benefited from a $16.5 million deferred tax asset valuation allowance reduction.
|
|
•
|
On May 10, 2013, the Company acquired Florida Chemical Company, one of the world’s largest processor of citrus oils. The acquisition price of $106.4 million was funded through the issuance of 3.2 million shares of the Company’s common stock and $53.7 million in cash.
|
|
•
|
In conjunction with the Florida Chemical acquisition, the Company entered into an amended and restated credit facility. The amended credit facility provided for a $50 million term loan and provides for a revolving credit facility of up to $75 million.
|
|
•
|
The Company’s outstanding convertible notes balance at par value was reduced by $101.3 million during 2012. On February 15, 2013, the Company repurchased the remaining $5.2 million of the outstanding convertible notes. As a result, the Company no longer has any outstanding convertible notes.
|
|
•
|
The Company has continued to reduce its debt during 2013 and 2014. At December 31, 2014, the Company’s debt was $44.0 million.
|
|
•
|
The Company is successfully expanding into foreign markets. Revenue from services and products used in foreign countries increased to 17.6% of consolidated revenue in 2014 compared to 12.7% of consolidated revenue in 2012. Additionally, in November 2013, the Company signed a shareholder agreement with Tasneea Oil and Gas Technologies, LLC to form Omani corporations that will develop and market specialty chemistries for the oil and gas industry throughout the Middle East and North Africa to facilitate growing international presence.
|
|
•
|
The Company continues to emphasize and expand its research and innovation activities. These activities focus on improvement of existing products and services, the design of reservoir specific, customized chemistries and the development of new products, processes and services. Research and innovation expense increased to $5.0 million in 2014 compared to $3.2 million in 2012.
|
|
•
|
During 2014, the Company acquired a company that is a leading Enhanced Oil Recovery design and injection firm and a company that provides reservoir engineering and modeling services for a variety of hydrocarbon applications. These acquisitions fit with the Company’s existing products and services and provide an opportunity to expand the Company’s customer base. In early 2015, the Company acquired the assets of a business that will allow the Company to control the manufacturing and service quality of next-generation hydraulic pumping units.
|
|
•
|
In May 2014, the Company launched its patent pending FracMax
TM
software technology that allows the Company to quantitatively demonstrate the benefits associated with the use of the Company’s patented and proprietary Complex nano-Fluid
TM
chemistries. The Company has integrated the use of the FracMax
TM
software technology into its sales and marketing activities resulting in a significant increase in interest in the Company’s Complex nano-Fluid
TM
chemistries.
|
|
•
|
A thorough review of compensation strategies and objectives;
|
|
•
|
A review of and recommended changes to the Chief Executive Officer’s employment agreement and other executive employment agreements, including adoption of “double-trigger” cash severance and equity acceleration following a change-in-control;
|
|
•
|
Adoption of a claw-back policy;
|
|
•
|
A review of policies and recommended changes relating to prohibited hedging transactions and the prohibition of pledging Company securities;
|
|
•
|
Adoption of stock ownership guidelines for executives and directors;
|
|
•
|
A review and update of the composition of the Peer Group;
|
|
•
|
A restructuring and refinement of executive annual cash bonus opportunities making amounts earned under the program primarily contingent on financial measures that drive shareholder returns; and
|
|
•
|
Adoption of an annual equity-based long-term incentive component to total compensation based on the Company’s financial performance and the Company’s performance relative to a peer group.
|
|
Name
|
|
Title
|
|
John W. Chisholm
(1)
|
|
Chairman of the Board, President and Chief Executive Officer
|
|
Steven A. Reeves
(2)
|
|
Executive Vice President, Operations
|
|
Joshua A. Snively, Sr.
(3)
|
|
Executive Vice President, Research and Innovation and President of Florida Chemical Co.
|
|
H. Richard Walton
(4)
|
|
Executive Vice President and Chief Financial Officer
|
|
M. Kevin Fisher
(5)
|
|
Executive Vice President, Global Business Development
|
|
(1)
|
Mr. Chisholm was appointed Interim President under the terms of a Service Agreement effective August 11, 2009, and became President on August 12, 2010. Mr. Chisholm was elected Chairman of the Board on July 13, 2010. Mr. Chisholm was appointed Chief Executive Officer effective March 5, 2012.
|
|
(2)
|
Mr. Reeves was appointed Executive Vice President, Operations effective May 19, 2011. He previously served as Executive Vice President, Operations, Business Development and Special Projects, Executive Vice President, Business Development and Special Projects, and Executive Vice President and Chief Operating Officer.
|
|
(3)
|
Mr. Snively was appointed President of Florida Chemical Company, Inc. effective May 10, 2013 and was appointed Executive Vice President, Research and Innovation, effective November 4, 2013.
|
|
(4)
|
Mr. Walton was appointed Executive Vice President and Chief Financial Officer effective March 13, 2013.
|
|
(5)
|
Mr. Fisher was appointed Executive Vice President, Global Business Development effective November 30, 2011. Mr. Fisher retired as Executive Vice President, Global Business Development effective March 18, 2014.
|
|
•
|
Compensation Committee chaired by an independent non-employee director. All Compensation Committee members are independent;
|
|
•
|
Representation from the Audit Committee on the Compensation Committee;
|
|
•
|
Review of executive compensation programs by the Compensation Committee’s independent compensation consultant;
|
|
•
|
Robust review of compensation program elements and key performance drivers; and
|
|
•
|
Detailed measurement of short- and long-term compensation elements to ensure balance.
|
|
•
|
The Company has strong internal financial controls that are assessed by the Company’s independent public accountants annually in addition to their audits of the Company’s financial statements.
|
|
•
|
Base salaries are generally consistent with market practice and the employees’ responsibilities so that employees are not motivated to take excessive risks to attain a reasonable level of financial security.
|
|
•
|
The determination of incentive awards is based on well-defined financial measures. There is a maximum incentive opportunity for each named executive officer, and the Committee retains discretion to adjust bonuses to eliminate anomalous or inappropriate outcomes.
|
|
•
|
Long-term incentives are designed to provide appropriate awards for successful outcomes, and effectively align realized compensation with returns realized by investors.
|
|
•
|
Since December 31, 2012, the Company has had a claw-back policy that covers executive officers and other officers who participate in the Company’s incentive plans. This policy permits the Company to recover incentive compensation awarded or paid if there is a subsequent change to a performance measure and in instances where an officer engaged in intentional misconduct.
|
|
•
|
All officers and directors are prohibited from purchasing or selling Company securities while in possession of material, non-public information. All officers and directors must pre-clear any transactions involving Flotek common stock with the Company’s Compliance Officer.
|
|
•
|
In 2014, the Company clarified its Insider Trading Policy with respect to its hedging policy and its pledging policy. Hedging transactions are prohibited and the pledging of Company securities to secure indebtedness is prohibited.
|
|
•
|
The Company has established formal stock ownership guidelines. These guidelines, based on base salary for executive officers and on the annual cash retainer for directors, help ensure that their interests are aligned with those of our stockholders.
|
|
•
|
The Company has a Code of Business Conduct and Ethics. This Code requires each employee and director to sign a Compliance Certification. In addition, all employees are required to complete annual anti-bribery training.
|
|
•
|
Attract and retain talented and experienced executives with the skills necessary to run and grow our existing business segments;
|
|
•
|
Align the interests of our executive officers with those of stockholders to increase the value of our enterprise;
|
|
•
|
Motivate and reward executives whose knowledge, skills and performance are critical to our success;
|
|
•
|
Demonstrate fairness among the executive management team by recognizing the contributions each executive makes to our success;
|
|
•
|
Provide that executives are accountable to the Board for their performance; and
|
|
•
|
Encourage a shared commitment among executives by coordinating Company and individual business unit targets, goals and objectives.
|
|
Basic Energy Services, Inc.
|
|
Newpark Resources, Inc.
|
|
CARBO Ceramics Inc.
|
|
Parker Drilling Company
|
|
C&J Energy Services, Inc.
|
|
RPC, Inc.
|
|
Key Energy Services, Inc.
|
|
Tesco Corporation
|
|
Layne Christensen Company
|
|
TETRA Technologies, Inc.
|
|
Matrix Service Company
|
|
|
|
Role
|
Guideline
|
|
Chief Executive Officer
|
6 times base salary
|
|
Other executive officers
|
3 times base salary
|
|
Directors
|
5 times annual retainer
|
|
•
|
Base salary;
|
|
•
|
Annual bonus incentive opportunities; and
|
|
•
|
Equity compensation under the long-term incentive plans.
|
|
Name
|
Base Salary
|
Annual
Bonus Target
|
LTIP Grant Value
|
Total
|
|
John W. Chisholm
|
22.7%
|
20.5%
|
56.8%
|
100%
|
|
Steven A. Reeves
|
29.9%
|
17.9%
|
52.2%
|
100%
|
|
Joshua A. Snively, Sr.
|
29.9%
|
17.9%
|
52.2%
|
100%
|
|
H. Richard Walton
|
28.6%
|
17.1%
|
54.3%
|
100%
|
|
M. Kevin Fisher *
|
100.0%
|
—%
|
—%
|
100%
|
|
Name
|
|
Title
|
|
Beginning
Salary
|
|
New Salary
|
|
|
Percent Increase
|
|
Steven A. Reeves
|
|
EVP, Operations
|
|
$405,000
|
|
$418,000
|
|
|
3.21%
|
|
Joshua A. Snively, Sr.
|
|
EVP, Research and Innovation
|
|
$377,500
|
|
$392,600
|
|
|
4.00%
|
|
H. Richard Walton
|
|
EVP and Chief Financial Officer
|
|
$325,000
|
|
$336,000
|
|
|
3.38%
|
|
M. Kevin Fisher
|
|
EVP, Global Business Development
|
|
$390,000
|
|
*
|
|
|
*
|
|
2014 Cash Bonus Performance Measure
|
||||
|
Adjusted EBITDA:
|
|
|
||
|
Minimum (50%)
|
|
Target (100%)
|
|
Maximum (200%)
|
|
$95.0 million
|
|
$115.0 million
|
|
$130.0 million
|
|
|
|
Minimum
|
|
Target
|
|
Maximum
|
|
Actual*
|
|
|
|
|
50%
|
|
100%
|
|
200%
|
|
97.5%
|
|
|
John W. Chisholm
|
|
$351,000
|
|
$702,000
|
|
$1,404,000
|
|
|
$684,450
|
|
Steven A. Reeves
|
|
$125,400
|
|
$250,800
|
|
$501,600
|
|
|
$244,530
|
|
Joshua A. Snively, Sr.
|
|
$117,780
|
|
$235,560
|
|
$471,120
|
|
|
$229,671
|
|
H. Richard Walton
|
|
$100,800
|
|
$201,600
|
|
$403,200
|
|
|
$196,560
|
|
Percent of Base Salary
|
|
|
John W. Chisholm
|
250%
|
|
Steven A. Reeves
|
175%
|
|
Joshua A. Snively, Sr.
|
175%
|
|
H. Richard Walton
|
190%
|
|
|
Minimum
|
|
Target
|
|
Maximum
|
|
Actual
|
|
Performance Percentage
|
50%
|
|
100%
|
|
200%
|
|
200%
|
|
Number of peers outperformed
(1)
|
2
|
|
5
|
|
8
|
|
10
|
|
Amounts in Shares
|
|
|
|
|
|
|
|
|
John W. Chisholm
|
37,129
|
|
74,258
|
|
148,516
|
|
148,516
|
|
Steven A. Reeves
|
13,929
|
|
27,857
|
|
55,714
|
|
55,714
|
|
Joshua A. Snively, Sr.
|
13,082
|
|
26,164
|
|
52,328
|
|
52,328
|
|
H. Richard Walton
|
12,156
|
|
24,311
|
|
48,622
|
|
48,622
|
|
Chief Executive Base Salary
|
|||
|
John W. Chisholm *
|
$
|
820,000
|
|
|
Executive Officer Base Salary
|
|||
|
Steven A. Reeves
|
$
|
435,000
|
|
|
Joshua A. Snively, Sr.
|
$
|
409,000
|
|
|
H. Richard Walton
|
$
|
350,000
|
|
|
Percent of Base Salary
|
||
|
John W. Chisholm
|
100
|
%
|
|
Steven A. Reeves
|
75
|
%
|
|
Joshua A. Snively, Sr.
|
60
|
%
|
|
H. Richard Walton
|
70
|
%
|
|
Percent of Base Salary
|
||
|
John W. Chisholm
|
375
|
%
|
|
Steven A. Reeves
|
200
|
%
|
|
Joshua A. Snively, Sr.
|
190
|
%
|
|
H. Richard Walton
|
200
|
%
|
|
Name and Principal Position
|
|
Year
|
|
Salary
|
|
Bonus
|
|
|
Stock
Awards
|
|
|
Option
Awards
|
|
|
All Other
Compensation
|
|
|
Total
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
John W. Chisholm – President, Chief Executive Officer and Chairman of the Board
|
|
2014
|
|
$
|
50,000
|
|
|
$
|
1,234,450
|
|
(1)
|
|
$
|
3,663,147
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
722,500
|
|
|
|
$
|
5,670,097
|
|
|
|
|
2013
|
|
$
|
48,000
|
|
|
$
|
450,000
|
|
|
|
$
|
1,612,519
|
|
|
|
$
|
—
|
|
|
|
$
|
686,750
|
|
|
|
$
|
2,797,269
|
|
|
|
|
2012
|
|
$
|
48,000
|
|
|
$
|
1,112,000
|
|
|
|
$
|
2,540,229
|
|
|
|
$
|
—
|
|
|
|
$
|
647,000
|
|
|
|
$
|
4,347,229
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Steven A. Reeves – Executive Vice President, Operations
|
|
2014
|
|
$
|
414,500
|
|
|
$
|
454,530
|
|
(1)
|
|
$
|
1,374,186
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
21,924
|
|
|
|
$
|
2,265,140
|
|
|
|
|
2013
|
|
$
|
405,000
|
|
|
$
|
182,250
|
|
|
|
$
|
621,267
|
|
|
|
$
|
—
|
|
|
|
$
|
20,109
|
|
|
|
$
|
1,228,626
|
|
|
|
|
2012
|
|
$
|
324,500
|
|
|
$
|
389,400
|
|
|
|
$
|
965,383
|
|
|
|
$
|
—
|
|
|
|
$
|
16,847
|
|
|
|
$
|
1,696,130
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Joshua A. Snively, Sr.– Executive Vice President, Research and Innovation and President of Florida Chemical Company, Inc.
|
|
2014
|
|
$
|
388,535
|
|
|
$
|
549,546
|
|
(1)
|
|
$
|
1,786,141
|
|
(2)(3)
|
|
$
|
—
|
|
|
|
$
|
1,819
|
|
|
|
$
|
2,726,041
|
|
|
|
|
2013
|
|
$
|
232,308
|
|
|
$
|
—
|
|
|
|
$
|
—
|
|
|
|
$
|
—
|
|
|
|
$
|
1,819
|
|
|
|
$
|
234,127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
H. Richard Walton – Executive Vice President and Chief Financial Officer
|
|
2014
|
|
$
|
333,039
|
|
|
$
|
391,560
|
|
(1)
|
|
$
|
1,199,262
|
|
(2)
|
|
$
|
—
|
|
|
|
$
|
6,661
|
|
|
|
$
|
1,930,522
|
|
|
|
|
2013
|
|
$
|
252,161
|
|
|
$
|
146,250
|
|
|
|
$
|
568,735
|
|
|
|
$
|
—
|
|
|
|
$
|
4,000
|
|
|
|
$
|
971,146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
M. Kevin Fisher – Executive Vice President, Global Business Development*
|
|
2014
|
|
$
|
139,500
|
|
|
$
|
210,000
|
|
(1)
|
|
$
|
—
|
|
|
|
$
|
—
|
|
|
|
$
|
6,482
|
|
|
|
$
|
355,982
|
|
|
|
|
2013
|
|
$
|
390,000
|
|
|
$
|
175,500
|
|
|
|
$
|
595,026
|
|
|
|
$
|
—
|
|
|
|
$
|
17,051
|
|
|
|
$
|
1,177,577
|
|
|
|
|
2012
|
|
$
|
305,000
|
|
|
$
|
366,000
|
|
|
|
$
|
907,374
|
|
|
|
$
|
—
|
|
|
|
$
|
16,954
|
|
|
|
$
|
1,595,328
|
|
|
Name
|
|
Year
|
|
Company
Provided
Vehicle
(1)
|
|
Company
Provided
Housing
|
|
Company
Match
401 (k)
|
|
Services and
Consulting
Contracts
(2)
|
|
All Other
Compensation
|
||||||||||
|
John W. Chisholm
|
|
2014
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
722,500
|
|
|
$
|
722,500
|
|
|
|
|
2013
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
686,750
|
|
|
$
|
686,750
|
|
|
|
|
2012
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
647,000
|
|
|
$
|
647,000
|
|
|
Steven A. Reeves
|
|
2014
|
|
$
|
600
|
|
|
$
|
13,034
|
|
|
$
|
8,290
|
|
|
$
|
—
|
|
|
$
|
21,924
|
|
|
|
|
2013
|
|
$
|
600
|
|
|
$
|
12,030
|
|
|
$
|
7,479
|
|
|
$
|
—
|
|
|
$
|
20,109
|
|
|
|
|
2012
|
|
$
|
600
|
|
|
$
|
9,720
|
|
|
$
|
6,527
|
|
|
$
|
—
|
|
|
$
|
16,847
|
|
|
Joshua A. Snively, Sr.
|
|
2014
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,819
|
|
|
$
|
—
|
|
|
$
|
1,819
|
|
|
|
|
2013
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,819
|
|
|
$
|
—
|
|
|
$
|
1,819
|
|
|
H. Richard Walton
|
|
2014
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,661
|
|
|
$
|
—
|
|
|
$
|
6,661
|
|
|
|
|
2013
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,000
|
|
|
$
|
—
|
|
|
$
|
4,000
|
|
|
M. Kevin Fisher *
|
|
2014
|
|
$
|
3,692
|
|
|
$
|
—
|
|
|
$
|
2,790
|
|
|
$
|
—
|
|
|
$
|
6,482
|
|
|
|
|
2013
|
|
$
|
12,000
|
|
|
$
|
—
|
|
|
$
|
5,051
|
|
|
$
|
—
|
|
|
$
|
17,051
|
|
|
|
|
2012
|
|
$
|
12,000
|
|
|
$
|
—
|
|
|
$
|
4,954
|
|
|
$
|
—
|
|
|
$
|
16,954
|
|
|
Name
|
|
Grant
Date
|
|
Estimated Future Payouts
Under Non-Equity Incentive
Plan Awards
|
|
Estimated Future Payouts
Under Equity Incentive
Plan Awards
|
|
All Other Stock Awards: Number of Shares of Stock or Units
|
All Other
Option
Awards:
Number of
Securities
Underlying
Options
|
Exercise or Base Price of Option Awards
|
|
Grant Date
Fair Value
for Stock
and
Option
Awards
|
|
||||||||||||||||||||||
|
Threshold
|
Target
(1)
|
Maximum
|
Threshold
(Shares)
|
Target
(Shares)
|
Maximum
(Shares)
|
|
|
||||||||||||||||||||||||||||
|
John W. Chisholm
|
|
3/27/2014
|
|
$
|
351,000
|
|
$
|
702,000
|
|
$
|
1,404,000
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
3/27/2014
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
37,129
|
|
74,258
|
|
148,516
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
3,663,147
|
|
(2
|
)
|
|
Steven A. Reeves
|
|
3/27/2014
|
|
$
|
125,400
|
|
$
|
250,800
|
|
$
|
501,600
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
3/27/2014
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
13,929
|
|
27,857
|
|
55,714
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
1,374,186
|
|
(2
|
)
|
|
Joshua A. Snively, Sr.
|
|
2/5/2014
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
—
|
|
—
|
|
—
|
|
|
22,379
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
495,471
|
|
(3
|
)
|
|
|
|
3/27/2014
|
|
$
|
117,780
|
|
$
|
235,560
|
|
$
|
471,120
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
3/27/2014
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
13,082
|
|
26,164
|
|
52,328
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
1,290,670
|
|
(2
|
)
|
|
H. Richard Walton
|
|
3/27/2014
|
|
$
|
100,800
|
|
$
|
201,600
|
|
$
|
403,200
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
3/27/2014
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
12,156
|
|
24,311
|
|
48,622
|
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
1,199,262
|
|
(2
|
)
|
|
(1)
|
At the date of grant, Mr. Chisholm, Mr. Reeves, Mr. Snively and Mr. Walton elected to received one-half of the target value of their 2014 Annual Bonus Plan (MIP) opportunity in the form of restricted shares. The value assigned to determine the shares, and the number of shares, based on the closing stock price on March 27, 2014, were as follows: Mr. Chisholm -
$351,000
,
13,366
shares; Mr. Reeves -
$125,400
,
4,775
shares; Mr. Snively -
$117,780
,
4,485
shares; and Mr. Walton -
$100,800
,
3,838
shares.
|
|
(2)
|
Grant date fair value is determined in accordance with ASC Topic 718 and, for the performance-based restricted share units which have a market condition, is the value at grant date based on the probable outcome of the performance condition and is consistent with the estimate of aggregate compensation cost to be recognized over the service period.
|
|
Option Awards
|
|||||||||||||||||
|
Name
|
|
Year of
Grant
|
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
|
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
|
|
Equity Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
|
|
Option
Exercise
Price
|
|
Option
Expiration
Date
|
|||||
|
John W. Chisholm
|
|
2005
|
|
20,000
|
|
|
—
|
|
|
—
|
|
|
$
|
9.40
|
|
|
12/21/2015
|
|
|
|
2009
|
|
26,668
|
|
|
—
|
|
|
—
|
|
|
$
|
2.51
|
|
|
2/16/2015
|
|
|
|
2009
|
|
400,000
|
|
|
—
|
|
|
—
|
|
|
$
|
1.02
|
|
|
12/22/2015
|
|
|
|
2010
|
|
300,000
|
|
|
—
|
|
|
—
|
|
|
$
|
2.17
|
|
|
11/10/2016
|
|
|
|
2011
|
|
400,000
|
|
|
—
|
|
|
—
|
|
|
$
|
9.19
|
|
|
4/8/2017
|
|
Steven A. Reeves
|
|
2011
|
|
200,000
|
|
|
—
|
|
|
—
|
|
|
$
|
9.19
|
|
|
4/8/2017
|
|
Restricted Stock Awards
|
||||||||||||||||||||||
|
Name
|
|
Year of Grant
|
|
Number of
Shares or Units of Stock
That Have Not
Vested
|
|
|
|
Market Value of Shares or Units of Stock
That Have Not Vested
(1)
|
|
Equity Incentive Plan
Awards: Number of
Unearned Shares, Units
or Other Rights That
Have Not Vested
|
|
|
|
Equity Incentive Plan
Awards: Market or
Payout Value of
Unearned Shares, Units
or Other Rights That
Have Not Vested
(1)
|
||||||||
|
John W. Chisholm
|
|
2012
|
|
13,535
|
|
|
(2
|
)
|
|
$
|
253,511
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
|
|
2013
|
|
49,312
|
|
|
(3
|
)
|
|
$
|
923,614
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
|
|
2014
|
|
—
|
|
|
|
|
$
|
—
|
|
|
13,366
|
|
|
(6
|
)
|
|
$
|
250,345
|
|
|
|
|
|
2014
|
|
—
|
|
|
|
|
$
|
—
|
|
|
74,258
|
|
|
(7
|
)
|
|
$
|
1,390,852
|
|
|
|
Steven A. Reeves
|
|
2012
|
|
5,144
|
|
|
(2
|
)
|
|
$
|
96,347
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
|
|
2013
|
|
18,998
|
|
|
(3
|
)
|
|
$
|
355,833
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
|
|
2014
|
|
—
|
|
|
|
|
$
|
—
|
|
|
4,775
|
|
|
(6
|
)
|
|
$
|
89,436
|
|
|
|
|
|
2014
|
|
—
|
|
|
|
|
$
|
—
|
|
|
27,857
|
|
|
(7
|
)
|
|
$
|
521,762
|
|
|
|
Joshua A. Snively, Sr.
|
|
2014
|
|
14,919
|
|
|
(4
|
)
|
|
$
|
279,433
|
|
|
—
|
|
|
|
|
|
$
|
—
|
|
|
|
|
2014
|
|
—
|
|
|
|
|
$
|
—
|
|
|
4,485
|
|
|
(6
|
)
|
|
$
|
84,004
|
|
|
|
|
|
2014
|
|
—
|
|
|
|
|
$
|
—
|
|
|
26,164
|
|
|
(7
|
)
|
|
$
|
490,052
|
|
|
|
H. Richard Walton
|
|
2013
|
|
17,393
|
|
|
(3
|
)
|
|
$
|
325,771
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
|
|
2013
|
|
25,000
|
|
|
(5
|
)
|
|
$
|
468,250
|
|
|
—
|
|
|
|
|
$
|
—
|
|
|
|
|
|
2014
|
|
—
|
|
|
|
|
$
|
—
|
|
|
3,838
|
|
|
(6
|
)
|
|
$
|
71,886
|
|
|
|
|
|
2014
|
|
—
|
|
|
|
|
$
|
—
|
|
|
24,311
|
|
|
(7
|
)
|
|
$
|
455,345
|
|
|
|
|
|
Option Awards
|
|
Restricted Stock Awards
|
||||||||||
|
Name
|
|
Number of
Shares Acquired
on Exercise
|
|
Value Realized
on Exercise
|
|
Number of
Shares Acquired
on Vesting
|
|
Value Realized
on Vesting
|
||||||
|
John W. Chisholm
|
|
4,960
|
|
|
$
|
20,842
|
|
|
151,283
|
|
|
$
|
3,803,365
|
|
|
Steve A. Reeves
|
|
16,404
|
|
|
$
|
74,817
|
|
|
114,664
|
|
|
$
|
3,004,262
|
|
|
Joshua A. Snively, Sr.
|
|
—
|
|
|
$
|
—
|
|
|
7,460
|
|
|
$
|
165,164
|
|
|
H. Richard Walton
|
|
—
|
|
|
$
|
—
|
|
|
39,660
|
|
|
$
|
983,822
|
|
|
M. Kevin Fisher *
|
|
—
|
|
|
$
|
—
|
|
|
54,014
|
|
|
$
|
1,358,028
|
|
|
Name and Participant Position
|
|
Termination
Event
|
|
Salary
|
|
Bonus
|
|
Health Benefits
|
|
Acceleration
of Unvested
Equity
|
|
Total
|
||||||||||
|
John W. Chisholm (1)
|
|
Change In Control
|
|
$
|
1,560,000
|
|
|
$
|
1,404,000
|
|
|
$
|
—
|
|
|
$
|
2,567,977
|
|
|
$
|
5,531,977
|
|
|
President, Chief Executive Officer and
|
|
Good Reason
|
|
$
|
1,560,000
|
|
|
$
|
1,404,000
|
|
|
$
|
—
|
|
|
$
|
253,511
|
|
|
$
|
3,217,511
|
|
|
Chairman of the Board
|
|
Without Cause
|
|
$
|
1,560,000
|
|
|
$
|
1,404,000
|
|
|
$
|
—
|
|
|
$
|
253,511
|
|
|
$
|
3,217,511
|
|
|
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,567,977
|
|
|
$
|
2,567,977
|
|
|
Steve A. Reeves (2)
|
|
Change In Control
|
|
$
|
278,667
|
|
|
$
|
167,200
|
|
|
$
|
26,814
|
|
|
$
|
973,929
|
|
|
$
|
1,446,610
|
|
|
Executive Vice President, Operations
|
|
Good Reason
|
|
$
|
278,667
|
|
|
$
|
167,200
|
|
|
$
|
26,814
|
|
|
$
|
96,341
|
|
|
$
|
569,022
|
|
|
|
|
Without Cause
|
|
$
|
278,667
|
|
|
$
|
167,200
|
|
|
$
|
26,814
|
|
|
$
|
96,341
|
|
|
$
|
569,022
|
|
|
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
973,929
|
|
|
$
|
973,929
|
|
|
Joshua A. Snively, Sr. (3)
|
|
Change In Control
|
|
$
|
294,450
|
|
|
$
|
176,670
|
|
|
$
|
—
|
|
|
$
|
769,485
|
|
|
$
|
1,240,605
|
|
|
Executive Vice President, Research &
|
|
Good Reason
|
|
$
|
294,450
|
|
|
$
|
176,670
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
471,120
|
|
|
Innovation, President of Florida
|
|
Without Cause
|
|
$
|
294,450
|
|
|
$
|
176,670
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
471,120
|
|
|
Chemical Company, Inc.
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
769,485
|
|
|
$
|
769,485
|
|
|
H. Richard Walton (4)
|
|
Change In Control
|
|
$
|
252,000
|
|
|
$
|
151,200
|
|
|
$
|
—
|
|
|
$
|
1,249,372
|
|
|
$
|
1,652,572
|
|
|
Executive Vice President and
|
|
Good Reason
|
|
$
|
252,000
|
|
|
$
|
151,200
|
|
|
$
|
—
|
|
|
$
|
468,250
|
|
|
$
|
871,450
|
|
|
Chief Financial Officer
|
|
Without Cause
|
|
$
|
252,000
|
|
|
$
|
151,200
|
|
|
$
|
—
|
|
|
$
|
468,250
|
|
|
$
|
871,450
|
|
|
|
|
Death or Disability
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,249,372
|
|
|
$
|
1,249,372
|
|
|
(i)
|
Any person (subject to certain exceptions) becomes the beneficial owner, directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities;
|
|
(ii)
|
During any period of one (1) year, individuals who at the beginning of such period constitute the Board (and any new Director whose election by the Corporation’s stockholders was approved by a vote of at least two-thirds (2/3) of the Directors then still in office who either were Directors at the beginning of the period or whose election or nomination for election was so approved) cease for any reason to constitute a majority thereof; or
|
|
(iii)
|
(A) The sale or disposition of all or substantially all the Company’s assets, or (B) a merger, consolidation, or reorganization of the Company with or involving any other entity, other than a merger, consolidation, or reorganization that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the combined voting power of the securities of the Company (or such surviving entity) outstanding immediately after such merger, consolidation, or reorganization.
|
|
(i)
|
A material reduction of the employee's salary and employee benefits to which the employee was entitled immediately prior to such reduction;
|
|
(ii)
|
A material reduction in the duties, authority or responsibilities relative to the employee's duties, authority or responsibilities as in effect immediately prior to such reduction; or
|
|
(iii)
|
The relocation of the employee to a facility or a location more than fifty (50) miles from the employee's then present location;
|
|
(i)
|
An employee willfully fails to substantially perform the employee’s duties (other than any such failure resulting from the employee’s total and permanent disability) after a written demand for substantial performance has been delivered by the Company to the employee that specifically identifies the manner in which the Company believes that the employee has not substantially performed the employee’s duties, and the employee fails to remedy such failure within ten (10) calendar days after receiving such notice;
|
|
(ii)
|
An employee is convicted (by trial, plea of guilty or plea of nolo contendere) for committing an act of fraud, embezzlement, theft, or other act constituting a felony;
|
|
(iii)
|
An employee willfully engages in gross misconduct or willfully violates a Company or a subsidiary policy which is materially and demonstrably injurious to the Company and/or a subsidiary after a written demand to cease such misconduct or violation has been delivered by the Company to the employee that specifically identifies the manner in which the Company believes that the employee has violated this Paragraph (iii), and the employee fails to cease such misconduct or violation and remedy any injury suffered by the Company or the subsidiary as a result thereof within thirty (30) calendar days after receiving such notice. However, no act or failure to act, on the employee’s part shall be considered “willful” unless done, or omitted to be done, by the
|
|
(iv)
|
An employee commits a material breach of any noncompetition, confidentiality or similar agreement with the Company or a subsidiary, as determined under such agreement.
|
|
Director
|
Audit
|
Corporate
Governance
and
Nominating
|
Compensation
|
|
Kenneth T. Hern
|
X
|
C
|
X
|
|
John S. Reiland
|
C
|
X
|
X
|
|
L.V. “Bud” McGuire*
|
|
X
|
X
|
|
L. Melvin Cooper
|
X
|
X
|
X
|
|
Carla S. Hardy*
|
|
X
|
C
|
|
Ted D. Brown**
|
|
X
|
X
|
|
•
|
Appoint, determine funding for, oversee and replace (subject to stockholder ratification, if applicable) a firm of independent auditors to audit our financial statements;
|
|
•
|
Pre-approve all audit and non-audit services provided by our independent auditors;
|
|
•
|
Evaluate the qualifications, performance and independence of our independent auditors, and ensure the rotation of the lead (or concurring) audit partner;
|
|
•
|
Obtain and review a report of our independent auditors, at least annually, regarding compliance with their internal quality-control procedures;
|
|
•
|
Discuss with our independent auditors the overall scope and plans for their respective audits;
|
|
•
|
Discuss with management and our independent auditors the adequacy and effectiveness of the Company’s accounting and financial controls;
|
|
•
|
Meet with our independent auditors to discuss the conduct and findings of their respective audits;
|
|
•
|
Meet and review with management and our independent auditors the Company’s financial statements and the associated disclosures to be included in quarterly and annual reports to be filed with the SEC;
|
|
•
|
Discuss with management and our independent auditors significant financial reporting issues and judgments made in connection with the preparation of the Company’s financial statements;
|
|
•
|
Discuss periodically with management the Company’s plan with regards to issuing earnings press releases and providing financial information and earnings guidance to analysts and rating agencies;
|
|
•
|
Review any disclosures by the Company’s officers and other employees regarding significant deficiencies in the design and operation of the Company’s internal controls; and
|
|
•
|
Establish procedures for receiving and responding to concerns regarding accounting, internal accounting controls and auditing matters.
|
|
•
|
Review, at least annually, the structure of the Board to assure that the proper skills and experience are represented on the Board;
|
|
•
|
Recommend to the full Board candidates to fill vacancies on the Board as they occur;
|
|
•
|
Recommend, prior to each annual stockholder meeting, a slate of nominees for election or reelection as directors by the stockholders at the annual meeting;
|
|
•
|
Identify individuals qualified to serve as potential Board members, consistent with criteria approved by the Board;
|
|
•
|
Select, evaluate, retain, and where appropriate, terminate any search firm to be used to identify qualified director candidates;
|
|
•
|
Evaluate current directors for re-nomination to the Board or re-appointment to any Board committees, and assess the performance of such directors;
|
|
•
|
Periodically review the composition of the Board and its committees in light of the current challenges and needs of the Board, the Company and each committee of the Board, and determine whether it may be appropriate to add or remove individuals;
|
|
•
|
Consider rotation of the Chairman and members of the committees of the Board;
|
|
•
|
Consider candidates to serve as Board members that are submitted by stockholders of the Company;
|
|
•
|
Periodically make recommendations to the Board with respect to the size of the Board;
|
|
•
|
Review criteria and policies relating to director independence, service and tenure;
|
|
•
|
Recommend to the Board the membership of the Audit and Compensation Committees, including their Chairpersons;
|
|
•
|
Make recommendations to the Board regarding corporate governance matters and practices, including formulating and periodically reviewing Corporate Governance Guidelines to be adopted by the Board;
|
|
•
|
Develop and recommend to the Board the Company’s Corporate Governance Guidelines and at least annually, review and reassess the adequacy of such Corporate Governance Guidelines and recommend any proposed changes to the Board;
|
|
•
|
Be responsible for any tasks assigned to the Corporate Governance and Nominating Committee in the Company’s Corporate Governance Guidelines;
|
|
•
|
Oversee compliance with the Company’s Corporate Governance Guidelines and Code of Business Conduct and Ethics and report on such compliance to the Board;
|
|
•
|
Review and consider any requests for waivers of the Company’s Corporate Governance Guidelines or Code of Business Conduct and Ethics for the Company’s directors, executive officers and other senior financial officers, and make a recommendation to the Board with respect to such request for a waiver;
|
|
•
|
Review potential conflicts of interest involving directors and determine whether such director or directors may vote on any issue as to which there may be a conflict;
|
|
•
|
Review all related party transactions and determine whether such transactions are appropriate for the Company to undertake and, if so, approve such transactions;
|
|
•
|
Review periodically with the Company’s counsel, in light of changing conditions, new legislation and other developments, the Company’s Code of Business Conduct and Ethics and make recommendations to the Board for such changes as the Corporate Governance and Nominating Committee shall deem appropriate; and
|
|
•
|
Review executive development and executive succession plans, including succession planning strategies for the Company’s senior management positions.
|
|
•
|
Adopt compensation policies and programs that are consistent with corporate strategy and meet all legal requirements regarding reporting and administration of compensation matters;
|
|
•
|
Establish, in conjunction with executive management, the overall compensation strategy of the Company and review such strategy at least annually for alignment with the Company’s business strategy and with similar programs offered by the Company’s competitors;
|
|
•
|
Oversee the compensation and benefits programs applicable to all employees of the Company;
|
|
•
|
Adopt, amend or terminate corporate incentive programs (including short-term and long-term incentive and other similar programs), including establishment of performance standards, and determine the funding of such programs relative to previously established performance standards;
|
|
•
|
Review the Company’s employee benefit plans, including retirement and savings plans, and either recommend plan changes to the Board or amend such plans as appropriate;
|
|
•
|
Recommend to the Board the adoption of any new Company employee benefit plan or the termination of any existing employee benefit plan, as appropriate;
|
|
•
|
Review at least annually the Company’s investment strategies around and performance of the Company’s 401(k) plans;
|
|
•
|
Review and approve, at least annually, corporate goals and objectives relevant to compensation of the Company’s executive officers and employees who
|
|
•
|
Either as a Compensation Committee or in conjunction with the other independent directors (as directed by the Board), adopt a compensation strategy and determine and approve each executive officer’s and CEO Direct Report’s salary, bonuses, and other compensation based on the strategy and the evaluation of each executive officer’s and CEO Direct Report’s performance and considering the results of the most recent shareholder advisory vote on executive compensation;
|
|
•
|
Regarding individual executive officer’s and CEO Direct Report’s compensation, consider a number of factors that include but are not limited to the Company’s financial and operational performance, relative shareholder return, the value of similar incentive awards to executives at comparable companies and awards given in past years and the results of the most recent shareholder advisory vote on executive compensation;
|
|
•
|
Annually review and approve the annual base salaries and annual short-term and long-term incentive opportunities of the executive officers and CEO Direct Reports;
|
|
•
|
Periodically review and approve the following as they affect executive officers and CEO Direct Reports: elements of compensation other than salaries and annual incentives; employment and severance agreements; change-in-control agreements and change-in-control provisions affecting any element of compensation or benefits; and any special or supplemental compensation and benefits for the executive officers and CEO Direct Reports and individuals who formerly served as executive officers and CEO Direct Reports;
|
|
•
|
Award equity-based awards to executive officers, and CEO Direct Reports and to other employees of the Company pursuant to any plans approved by the Board which by its terms provide for administration by the Compensation Committee;
|
|
•
|
Make recommendations to the Board with respect to the compensation of Board members;
|
|
•
|
Assure that all compensation policies and programs comply with applicable laws and regulations;
|
|
•
|
Review and approve annual performance goals for performance-based compensation that is intended to be tax deductible under Section 162(m) of the Internal Revenue Code, determine whether the performance goals and objectives are attained and certify the level of attainment as applicable;
|
|
•
|
Review the Company’s compensation policies and practices to determine whether they encourage excessive risk-taking, discuss annually the relationship between risk management policies and practices and compensation, and evaluate compensation policies and practices that could mitigate any such risk;
|
|
•
|
Consider the factors affecting independence set forth in Section 303A.05(c)(iv) of the NYSE Listed Company Manual when selecting or soliciting advice from any
|
|
•
|
Review and approve the frequency that should be recommended to the Company’s shareholders with respect to how often the Company shall hold a shareholder advisory vote on executive compensation (“Say on Pay Vote”); review and approve the frequency with which the Company should submit to the shareholders a Say on Pay Vote, taking into consideration any prior Say on Pay Vote on the frequency with which the Company shall hold a Say on Pay Vote; and review the results of the most recent Say on Pay Vote when considering whether to make any adjustments to the Company’s executive compensation policies and practices;
|
|
•
|
Review and discuss the Company’s Compensation Discussion and Analysis (“CD&A”) and the related executive compensation information and recommend that the CD&A and related executive compensation information be included in the Company’s proxy statement and annual report on Form 10-K as required by the rules and regulations of the Securities and Exchange Commission;
|
|
•
|
Approve the Compensation Committee report on executive officer compensation included in the Company’s proxy statement or annual report on Form 10-K as required by the rules and regulations of the Securities and Exchange Commission;
|
|
•
|
Receive reports on compensation and benefits applicable to all employees; and
|
|
•
|
Oversee the Company’s compliance with, and take any other actions as may be required from time to time by, applicable law, the rules of the NYSE, the rules and regulations of the Securities and Exchange Commission, the Bylaws or the Board, including any requirement that shareholders approve equity compensation plans.
|
|
Name
|
|
Board
Retainer (1) |
|
Committee
Chair Retainer (1) |
|
Meeting
Fees (1) |
|
Restricted
Stock Awards (2)(3) |
|
Option Awards
(4)
|
|
Total
|
||||||||||||
|
Kenneth T. Hern
|
|
$
|
64,000
|
|
|
$
|
12,000
|
|
|
$
|
36,000
|
|
|
$
|
120,012
|
|
|
$
|
—
|
|
|
$
|
232,012
|
|
|
John S. Reiland
|
|
40,000
|
|
|
24,000
|
|
|
36,000
|
|
|
120,012
|
|
|
—
|
|
|
220,012
|
|
||||||
|
L.V. "Bud" McGuire
|
|
40,000
|
|
|
4,512
|
|
|
25,000
|
|
|
120,012
|
|
|
—
|
|
|
189,524
|
|
||||||
|
L. Melvin Cooper
|
|
40,000
|
|
|
—
|
|
|
36,000
|
|
|
120,012
|
|
|
—
|
|
|
196,012
|
|
||||||
|
Carla S. Hardy
|
|
40,000
|
|
|
7,480
|
|
|
30,000
|
|
|
120,012
|
|
|
—
|
|
|
197,492
|
|
||||||
|
Ted D. Brown
|
|
40,000
|
|
|
—
|
|
|
17,000
|
|
|
120,012
|
|
|
—
|
|
|
177,012
|
|
||||||
|
|
2014
|
|
2013
|
||||
|
Audit fees
|
$
|
691,247
|
|
|
$
|
697,751
|
|
|
Audit related fees
|
35,000
|
|
|
35,000
|
|
||
|
Tax fees
|
—
|
|
|
4,883
|
|
||
|
All other fees
|
—
|
|
|
—
|
|
||
|
Total
|
$
|
726,247
|
|
|
$
|
737,634
|
|
|
|
|
|
|
|
n
|
|
14475
|
n
|
|
¢
20630300000000000000 0
|
|
|
|
042415
|
|
PROPOSAL 1: Election of the seven directors to serve until next annual meeting of stockholders of the Company or until their successors are duly elected and qualified, or until their earlier resignation or removal.
|
||||||
|
|
|
|
|
NOMINEES:
|
|
|
|
¨
FOR ALL NOMINEES
|
|
○
John W. Chisholm
○
Kenneth T. Hern
○
John S. Reiland
|
||||
|
¨
WITHHOLD AUTHORITY
FOR ALL NOMINEES
|
|
○
L.V. “Bud” McGuire
○ L. Melvin Cooper ○ Carla S. Hardy ○ Ted D. Brown |
||||
|
¨
FOR ALL EXCEPT
(See instructions below)
|
|
|
||||
|
INSTRUCTIONS:
|
|
To withhold authority to vote for any individual nominee(s), mark “FOR ALL EXCEPT” and fill in the circle next to each nominee you wish to withhold, as shown here:
●
|
||||
|
|
|
|
|
|
|
|
|
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
|
¨
|
||||
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
PROPOSAL 2:
|
|
Approval of Non-Binding Advisory Vote on Executive Compensation.
|
|
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
PROPOSAL 3:
|
|
Ratification of the selection of the independent registered public accounting firm, HEIN & ASSOCIATES LLP, as the Company’s auditors for the year ending December 31, 2015.
|
|
|
|
¨
|
|
¨
|
|
¨
|
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
|
|
¢
|
|
¢
|
|
|
|
PROXY VOTING INSTRUCTIONS
|
|
|
|
TELEPHONE - Call toll-free 1-800-PROXIES (1-800-776-9437) in the United States or 1-718-921-8500 from foreign countries from any touch-tone telephone and follow the instructions. Have your proxy card available when you call.
Vote online/phone until 11:59 PM EST the day before the meeting.
|
|
|
|
|
|
COMPANY NUMBER
|
|
|
|
MAIL - Sign, date and mail your proxy card in the envelope provided as soon as possible.
|
|
ACCOUNT NUMBER
|
|
|
IN PERSON - You may vote your shares in person by attending the Annual Meeting.
|
|
|
|
|
NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIAL
:
The Notice of Meeting, proxy statement and proxy card
are available at www.flotekind.com/proxymaterials.
|
|
i
Please detach along perforated line and mail in the envelope provided
IF
you are not voting via telephone or the Internet.
i
|
|
¢
20630300000000000000 0
|
|
|
|
042415
|
|
PROPOSAL 1: Election of the seven directors to serve until next annual meeting of stockholders of the Company or until their successors are duly elected and qualified, or until their earlier resignation or removal.
|
||||||
|
|
|
|
|
NOMINEES:
|
|
|
|
¨
FOR ALL NOMINEES
|
|
○
John W. Chisholm
○
Kenneth T. Hern
○
John S. Reiland
|
||||
|
¨
WITHHOLD AUTHORITY
FOR ALL NOMINEES
|
|
○
L.V. “Bud” McGuire
○ L. Melvin Cooper ○ Carla S. Hardy ○ Ted D. Brown |
||||
|
¨
FOR ALL EXCEPT
(See instructions below)
|
|
|
||||
|
INSTRUCTIONS:
|
|
To withhold authority to vote for any individual nominee(s), mark “FOR ALL EXCEPT” and fill in the circle next to each nominee you wish to withhold, as shown here:
●
|
||||
|
|
|
|
|
|
|
|
|
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
|
¨
|
||||
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
PROPOSAL 2:
|
|
Approval of Non-Binding Advisory Vote on Executive Compensation.
|
|
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
PROPOSAL 3:
|
|
Ratification of the selection of the independent registered public accounting firm, HEIN & ASSOCIATES LLP, as the Company’s auditors for the year ending December 31, 2015.
|
|
|
|
¨
|
|
¨
|
|
¨
|
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
Signature of Stockholder
|
|
|
|
Date:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
|
|
n
|
|
|
n
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| International Flavors & Fragrances Inc. | IFF |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|